Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki, Tomihiro Imai, Hirokazu Shiraishi, Hidekazu Suzuki, Meinoshin Okumura, Fanny O'Brien, Jing-Jing Wang, Kenji P Fujita, Kimiaki Utsugisawa, REGAIN Study Group, John Vissing (Medlem af forfattergruppering)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab